Evaluating Knowledge And Awareness Of SGLT-2 Inhibitors’ Use, Efficacy, Side Effects, And Cardiovascular And Renal Impacts Among Primary Healthcare Physicians In Makkah, Saudi Arabia. The Review of Diabetic Studies , [S. l.], p. 490–500, 2025. DOI: 10.70082/rr96vh76. Disponível em: https://www.diabeticstudies.org/index.php/RDS/article/view/1081. Acesso em: 19 jan. 2026.